FDA NDC Directory · JSON-LD · Markdown

TYENNE

NDC 65219-592 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameTocilizumab-aazg
Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryBiologic License Application · App BLA761275
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsTOCILIZUMAB (200 mg/10mL)
Marketing started20240415
Package count1

External sources

Source: openFDA. Public-domain (CC0).